Cover Image
市場調查報告書

北美的生物性骨材市場未來展望

North America Orthobiologics Market Outlook to 2021

出版商 GlobalData 商品編碼 297556
出版日期 內容資訊 英文 226 Pages
訂單完成後即時交付
價格
Back to Top
北美的生物性骨材市場未來展望 North America Orthobiologics Market Outlook to 2021
出版日期: 2015年10月01日 內容資訊: 英文 226 Pages
簡介

本報告提供北美各國(美國·加拿大)生物性骨材(Orthobiologics:人工骨替代材料·關節內補充劑·自體骨移植片·骨生長刺激植入裝置等)市場現狀與未來發展預測相關分析,提供整體市場規模(以金額·數量為準)的實際成果值·預測值,及市場價格的轉變,市場佔有率(各流通管道·各企業),各國市場的詳細趨勢,再加上主要企業的概要與策略,開發中的產品,最新的市場動靜(資本交易等)等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 生物性骨材市場分類
  • 分析對象定義

第3章 北美的生物性骨材市場

  • 市場收益額趨勢(以金額為準,總計16年份)
  • 市場收益額趨勢:不同分類的比較(總計16年份)
  • 市場收益額的實際成果值(以金額為準,過去8年份)
  • 市場收益額的預測值(以金額為準,今後9年份)
  • 市場規模趨勢(以數量為準,總計16年份)
  • 市場規模的實際成果值(以數量為準,過去8年份)
  • 市場規模的預測值(以數量為準,今後9年份)
  • 各企業的市場佔有率(以金額為準)

第4章 加拿大的生物性骨材市場

  • 市場收益額的實際成果值(以金額為準,過去8年份)
  • 市場收益額的預測值(以金額為準,今後9年份)
    • 人工骨替代材料的市場收益額(總計16年份)
  • 市場規模的實際成果值(以數量為準,過去8年份)
  • 市場規模的預測值(以數量為準,今後9年份)
    • 人工骨替代材料的市場規模(總計16年份)
  • 平均價格趨勢(總計16年份)
  • 各流通型態市場佔有率(以金額為準)
  • 各企業的市場佔有率(以金額為準)

第5章 墨西哥的生物性骨材市場

第6章 美國的生物性骨材市場

第7章 主要企業概要

  • Medtronic, Inc.
  • DePuy Companies
  • Sanofi
  • Globus Medical, Inc.
  • NuVasive, Inc.
  • Stryker Corporation
  • Biomet, Inc.
  • DJO Finance LLC
  • Baxter International Inc.
  • Smith & Nephew Plc
  • Wright Medical Group, Inc.
  • Anika Therapeutics, Inc.
  • 生化學工業
  • Orthofix International N.V.

第8章 開發中產品

第9章 資本交易環境

  • 資產交易(1件)
  • 夥伴關係(1件)

第10章 近幾年的市場趨勢

  • corporate·通訊(全14件)
  • 財務相關資訊(全43件)
  • 政府·公益相關資訊(全24件)
  • 法律規章相關資訊(全7件)
  • 其他重要的動向(全8件)
  • 產品資訊(全6件)
  • 策略·產業計畫相關資訊(全3件)

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0277DB

GlobalData's new report, "North America Orthobiologics Market Outlook to 2021", provides key market data on the North America Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the North America Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, North America

  • 3.1. Orthobiologics Market, North America, Revenue ($m), 2007-2021
  • 3.2. Orthobiologics Market, North America, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Orthobiologics Market, North America, Revenue ($m), 2007-2014
  • 3.4. Orthobiologics Market, North America, Revenue ($m), 2014-2021
  • 3.5. Orthobiologics Market, North America, Volume (Units), 2007-2021
  • 3.6. Orthobiologics Market, North America, Volume (Units), 2007-2014
  • 3.7. Orthobiologics Market, North America, Volume (Units), 2014-2021
  • 3.8. Orthobiologics Market, North America, Company Share by Revenue ($m), 2014

4. Orthobiologics Market, Canada

  • 4.1. Orthobiologics Market, Canada, Revenue ($m), 2007-2014
  • 4.2. Orthobiologics Market, Canada, Revenue ($m), 2014-2021
    • 4.2.1. Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2014-2021
  • 4.3. Orthobiologics Market, Canada, Volume (Units), 2007-2014
  • 4.4. Orthobiologics Market, Canada, Volume (Units), 2014-2021
    • 4.4.1. Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2007-2014
    • 4.4.2. Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2014-2021
  • 4.5. Orthobiologics Market, Canada, Average Price ($), 2007-2021
  • 4.6. Orthobiologics Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 4.7. Orthobiologics Market, Canada, Company Share by Revenue ($m), 2014

5. Orthobiologics Market, Mexico

  • 5.1. Orthobiologics Market, Mexico, Revenue ($m), 2007-2014
  • 5.2. Orthobiologics Market, Mexico, Revenue ($m), 2014-2021
    • 5.2.1. Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2014-2021
  • 5.3. Orthobiologics Market, Mexico, Volume (Units), 2007-2014
  • 5.4. Orthobiologics Market, Mexico, Volume (Units), 2014-2021
    • 5.4.1. Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2007-2014
    • 5.4.2. Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2014-2021
  • 5.5. Orthobiologics Market, Mexico, Average Price ($), 2007-2021
  • 5.6. Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), 2013-2014
  • 5.7. Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2014

6. Orthobiologics Market, United States

  • 6.1. Orthobiologics Market, United States, Revenue ($m), 2007-2014
  • 6.2. Orthobiologics Market, United States, Revenue ($m), 2014-2021
    • 6.2.1. Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Viscosupplementation Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.4. Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2014-2021
    • 6.2.5. Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2014-2021
    • 6.2.6. Viscosupplementation Market, United States, Revenue ($m), by Segment, 2014-2021
  • 6.3. Orthobiologics Market, United States, Volume (Units), 2007-2014
  • 6.4. Orthobiologics Market, United States, Volume (Units), 2014-2021
    • 6.4.1. Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.2. Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.3. Viscosupplementation Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.4. Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2014-2021
    • 6.4.5. Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2014-2021
    • 6.4.6. Viscosupplementation Market, United States, Volume (Units), by Segment, 2014-2021
  • 6.5. Orthobiologics Market, United States, Average Price ($), 2007-2021
  • 6.6. Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 6.7. Orthobiologics Market, United States, Company Share by Revenue ($m), 2014

7. Overview of Key Companies in North America Orthobiologics Market

  • 7.1. Medtronic plc
    • 7.1.1. Company Overview
  • 7.2. DePuy Companies
    • 7.2.1. Company Overview
  • 7.3. Sanofi
    • 7.3.1. Company Overview
  • 7.4. Arthrex, Inc.
    • 7.4.1. Company Overview
  • 7.5. Stryker Corporation
    • 7.5.1. Company Overview
  • 7.6. Ferring International Center S.A.
    • 7.6.1. Company Overview
  • 7.7. Biomet, Inc. (Inactive)
    • 7.7.1. Company Overview
  • 7.8. DJO Finance LLC
    • 7.8.1. Company Overview
  • 7.9. Bioventus LLC
    • 7.9.1. Company Overview
  • 7.10. Baxter International Inc.
    • 7.10.1. Company Overview
  • 7.11. Seikagaku Corporation
    • 7.11.1. Company Overview
  • 7.12. Wright Medical Group, Inc.
    • 7.12.1. Company Overview

8. Orthobiologics Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Aug 27, 2015: ESC Congress 2015: BIOTRONIK Announces CE Approval and Pilot Study Results for BioMonitor 2
    • 9.1.2. Aug 13, 2015: Bone Biologics Appoints New Chief Executive Officer and a Chief Operating Officer
    • 9.1.3. Jul 30, 2015: Histogenics Announces Appointment of Stephen Kennedy to Chief Technology Officer
    • 9.1.4. Jul 15, 2015: Histogenics Announces Dr. Gloria Matthews as Chief Medical Officer
    • 9.1.5. Jun 25, 2015: GenomeDx's Decipher Prostate Cancer Classifier Accurately Predicts Metastasis Ten Years after Prostate Removal in Study Published by European Urology
    • 9.1.6. Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group
    • 9.1.7. Jun 22, 2015: Histogenics Announces Appointment of New Chief Financial Officer
    • 9.1.8. May 11, 2015: Histogenics Announces World Class Scientific Advisory Board to Support Commercialization and Pipeline Development
    • 9.1.9. May 04, 2015: Mayne Pharma Update
    • 9.1.10. Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine
    • 9.1.11. Feb 03, 2015: U.S. FDA Grants Priority Review for YONDELIS (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
    • 9.1.12. Feb 02, 2015: Histogenics Announces the Appointment of David Gill to Its Board of Directors and Chairman of Audit Committee
    • 9.1.13. Jan 14, 2015: Tissue Regeneration Systems Adds Business Development Executive
    • 9.1.14. Dec 09, 2014: Bone Biologics announces appointment of George Oram to its Board of Directors
    • 9.1.15. Nov 24, 2014: Alphatec Spine Announces Appointment of Tom C. Davis to Its Board of Directors
    • 9.1.16. Nov 12, 2014: Bone Biologics appoints Deina Walsh CFO
    • 9.1.17. Oct 10, 2014: Medtronic Announces Executive Leadership Team for Combined Organization Upon Close of Covidien Acquisition
    • 9.1.18. Sep 17, 2014: Medtronic Elects Elizabeth Nabel to the Board of Directors
  • 9.2. Financial Announcements
    • 9.2.1. Aug 25, 2015: Entellus Medical Surpasses 100,000 Patients Treated Worldwide
    • 9.2.2. Aug 22, 2015: HealthSpot disrupts the lab industry with plans to bring 7 minute blood tests to retail pharmacy clinics
    • 9.2.3. Aug 12, 2015: Histogenics Announces Second Quarter 2015 Financial and Operating Results
    • 9.2.4. Aug 04, 2015: Alphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results
    • 9.2.5. Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results
    • 9.2.6. Jul 30, 2015: RTI Surgical Announces 2015 Second Quarter Results
    • 9.2.7. Jul 29, 2015: Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress
    • 9.2.8. Jul 29, 2015: Wright Medical Group Reports 2015 Second Quarter Financial Results
    • 9.2.9. Jul 28, 2015: Exactech Q2 2015 Revenue $61.5 Million. Net Income $3.7 Million. Diluted EPS $0.26.
    • 9.2.10. Jul 23, 2015: Bard Announces Second Quarter Results
    • 9.2.11. Jun 25, 2015: Ventripoint Announces Development of New VMS Products and Enhanced Capabilities as Featured at ASE 2015
    • 9.2.12. Jun 23, 2015: Quotient Clinical begins prostate cancer project for Druggability Technologies
    • 9.2.13. Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results
    • 9.2.14. May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results
    • 9.2.15. May 18, 2015: Intra-Cellular Therapies Announces Further Analyses of the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 168th Annual Meeting of the American Psychiatric Association
    • 9.2.16. May 14, 2015: Histogenics Announces First Quarter 2015 Financial Results
    • 9.2.17. Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results
    • 9.2.18. Apr 30, 2015: Alphatec Holdings Announces First Quarter 2015 Revenue and Financial Results
    • 9.2.19. Apr 29, 2015: Wright Medical Group Reports 2015 First Quarter Financial Results
    • 9.2.20. Apr 28, 2015: Exactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30.
    • 9.2.21. Apr 23, 2015: Bard Announces First Quarter Results
    • 9.2.22. Apr 23, 2015: RTI Surgical Announces 2015 First Quarter Results
    • 9.2.23. Apr 20, 2015: ALR Technologies Signs First Revenue-Generating Contract
    • 9.2.24. Apr 15, 2015: Tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma
    • 9.2.25. Apr 01, 2015: Idera Announces FDA Orphan Drug Designation for IMO-8400 for the Treatment of Diffuse Large B-Cell Lymphoma
    • 9.2.26. Mar 11, 2015: The Medicines Company Provides new data on MDCO-216 at 2015 American College of Cardiology Scientific Sessions in San Diego
    • 9.2.27. Feb 26, 2015: Histogenics Announces Fourth Quarter and Full Year 2014 Financial Results
    • 9.2.28. Feb 26, 2015: Alphatec Holdings Announces Fourth Quarter and Full Year 2014 Revenue and Financial Results
    • 9.2.29. Feb 25, 2015: Wright Medical Group Reports 2014 Fourth Quarter and Full-Year Financial Results and Provides 2015 Guidance
    • 9.2.30. Feb 24, 2015: Integra LifeSciences Reports Fourth Quarter 2014 Financial Results
    • 9.2.31. Feb 17, 2015: Exactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18
    • 9.2.32. Feb 12, 2015: RTI Surgical Announces 2014 Fourth Quarter, Full Year Results, 2015 Financial Guidance
    • 9.2.33. Jan 29, 2015: Bard Announces Fourth Quarter Results
    • 9.2.34. Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine
    • 9.2.35. Jan 12, 2015: Wright Medical Group Announces Preliminary Fourth Quarter and Full Year 2014 Revenue
    • 9.2.36. Dec 10, 2014: Bard Declares Quarterly Dividend
    • 9.2.37. Dec 04, 2014: Ra Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Complement C5 Inhibitor at 2014 ASH Annual Meeting
    • 9.2.38. Dec 04, 2014: Oncolytics Biotech Collaborators Present REOLYSIN and Checkpoint Inhibitor Combination Preclinical Data at AACR Tumor Immunology and Immunotherapy Conference
    • 9.2.39. Dec 04, 2014: Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2015
    • 9.2.40. Nov 18, 2014: Medtronic Reports Second Quarter Earnings
    • 9.2.41. Nov 05, 2014: Wright Medical Group Reports 2014 Third Quarter Financial Results and Updated Guidance
    • 9.2.42. Nov 03, 2014: Integra LifeSciences Reports Third Quarter 2014 Financial Results
    • 9.2.43. Oct 30, 2014: Alphatec Holdings Announces Third Quarter 2014 Revenue and Financial Results
    • 9.2.44. Oct 27, 2014: Wright Medical Group Announces Third Quarter 2014 Revenue
    • 9.2.45. Oct 22, 2014: Two New Patents Published by the US Patent Office
    • 9.2.46. Oct 22, 2014: Nuvo Research Completes WF10 U.S. Market Study for Treatment of Refractory Allergies
    • 9.2.47. Oct 22, 2014: Bard Announces Third Quarter Results
    • 9.2.48. Oct 21, 2014: Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23
    • 9.2.49. Oct 08, 2014: Bard Declares Regular Quarterly Dividend
    • 9.2.50. Sep 16, 2014: Monarch CleanStream Evacuation System Cleaner Receives High Reviews in a Recent Peer-to-Peer Product Evaluation
  • 9.3. Government and Public Interest
    • 9.3.1. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
    • 9.3.2. Dec 12, 2014: RTI Surgical Hosts Winter Biologics Spine Symposium
    • 9.3.3. Oct 13, 2014: Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
  • 9.4. Legal And Regulatory
    • 9.4.1. Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard
    • 9.4.2. Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas
    • 9.4.3. Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures
    • 9.4.4. Feb 03, 2015: MTF Announces Filing of Inter Partes Review Petitions and Motion to Stay in Patent Infringement Litigation
    • 9.4.5. Jan 20, 2015: Integra LifeSciences Announces Resolution of Warning Letter Related to Its Manufacturing Facility in Anasco, Puerto Rico
  • 9.5. Other Significant Developments
    • 9.5.1. Jun 24, 2015: $4.5MM Verdict Reached against Wright Medical Technology says Legal-Bay Lawsuit Settlement Funding
    • 9.5.2. Apr 13, 2015: RTI Surgical Announces Agreement with Novation, One of the Nation's Leading Healthcare Services Companies
    • 9.5.3. Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE
    • 9.5.4. Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants
    • 9.5.5. Dec 16, 2014: Three Colorado Agencies Receive Medtronic Health Access Grant
    • 9.5.6. Dec 03, 2014: Medtronic Releases 2014 Integrated Performance Report
    • 9.5.7. Sep 29, 2014: Medtronic Extends Title Sponsorship of Twin Cities Marathon Through 2020
  • 9.6. Strategy And Business Planning
    • 9.6.1. Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine
    • 9.6.2. Jun 25, 2015: The Only Permanent, FDA-Cleared, Non-Invasive Solution to Underarm Sweat, Now Available at Boston Plastic Surgery
    • 9.6.3. Jun 24, 2015: LifeVac Registered With UK Ministry of Health
    • 9.6.4. Dec 22, 2014: MTF forms new wound care division to meet growing medical need
    • 9.6.5. Nov 03, 2014: Integra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company
    • 9.6.6. Oct 17, 2014: Collagen Solutions Provides Funded Research Collaboration with Jellagen
    • 9.6.7. Sep 25, 2014: Medigene to present at PIVAC Conference Rome
    • 9.6.8. Sep 22, 2014: Accellent Unveils its New Brand Identity as Lake Region Medical

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Market Modeling and Forecasting
    • 10.1.5. Company Share Analysis
    • 10.1.6. Distribution Share Analysis
  • 10.2. Expert Panel
  • 10.3. GlobalData Consulting
  • 10.4. Contact Us
  • 10.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Orthobiologics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Orthobiologics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Orthobiologics Market, North America, Volume (Units), 2007-2021
  • Table 6: Orthobiologics Market, North America, Volume (Units), Historic, 2007-2014
  • Table 7: Orthobiologics Market, North America, Volume (Units), Forecast, 2014-2021
  • Table 8: Orthobiologics Market, North America, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 13: Orthobiologics Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 14: Orthobiologics Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 15: Bone Grafts and Substitutes Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 16: Bone Grafts and Substitutes Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 17: Orthobiologics Market, Canada, Average Price ($) Historic, 2007-2014
  • Table 18: Orthobiologics Market, Canada, Average Price ($), Forecast, 2014-2021
  • Table 19: Orthobiologics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Orthobiologics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 22: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 23: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 24: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 25: Orthobiologics Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 26: Orthobiologics Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 27: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 28: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 29: Orthobiologics Market, Mexico, Average Price ($) Historic, 2007-2014
  • Table 30: Orthobiologics Market, Mexico, Average Price ($), Forecast, 2014-2021
  • Table 31: Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 32: Orthobiologics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014
  • Table 33: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 34: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 36: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 37: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 38: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 39: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 40: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 41: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014
  • Table 42: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 43: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014
  • Table 44: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014
  • Table 45: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014
  • Table 46: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 47: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 48: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 49: Orthobiologics Market, United States, Average Price ($) Historic, 2007-2014
  • Table 50: Orthobiologics Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 51: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 52: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 53: Orthobiologics Market Pipeline Products
  • Table 54: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Orthobiologics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Orthobiologics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Orthobiologics Market, North America, Volume (Units), 2007-2021
  • Figure 6: Orthobiologics Market, North America, Volume (Units), Historic, 2007-2014
  • Figure 7: Orthobiologics Market, North America, Volume (Units), Forecast, 2014-2021
  • Figure 8: Orthobiologics Market, North America, Company Share (%) 2014
  • Figure 9: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Orthobiologics Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 14: Orthobiologics Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 15: Bone Grafts and Substitutes Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 16: Bone Grafts and Substitutes Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 17: Orthobiologics Market, Canada, Company Share (%) 2014
  • Figure 18: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 21: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 22: Orthobiologics Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 23: Orthobiologics Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 24: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 25: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 26: Orthobiologics Market, Mexico, Company Share (%) 2014
  • Figure 27: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 28: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 29: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 32: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 33: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 35: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 36: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 37: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 38: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 39: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 40: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 41: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 42: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 43: Orthobiologics Market, United States, Company Share (%) 2014
  • Figure 44: GlobalData Epidemiology-Based Forecasting Model
  • Figure 45: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 46: Primary Interviews by Participant Type (%)
Back to Top